Sensei Biotherapeutics, Inc. · NASDAQ:SNSE

Ics Opportunities II LLC bought 30,585 and sold 3,250 Sensei Biotherapeutics, Inc. shares (Form 4)

Traded Mar 26 to Mar 30, 2026 · Filed May 15, 2026

From Mar 26 to Mar 30, 2026, Ics Opportunities II LLC (10% owner) bought 30,585 and sold 3,250 Sensei Biotherapeutics, Inc. shares, leaving 145,678 shares. Filed May 15, 2026 (Form 4).

Bought
30,585 shares (US$818K at an average US$26.75)
Sold
3,250 shares (US$89,394 at an average US$27.51)
Holding after
145,678 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 26, 2026Common StockBuy778US$27.23131,370Indirect
Mar 26, 2026Common StockBuy1,327US$27.95131,370Indirect
Mar 26, 2026Common StockBuy2,601US$28.85131,370Indirect
Mar 26, 2026Common StockBuy1,025US$29.98131,370Indirect
Mar 26, 2026Common StockSale583US$26.88131,370Indirect
Mar 26, 2026Common StockSale1,274US$28.69131,370Indirect
Mar 27, 2026Common StockBuy10,643US$26.29142,360Indirect
Mar 27, 2026Common StockBuy4,384US$27.28142,360Indirect
Mar 27, 2026Common StockBuy294US$28.13142,360Indirect
Mar 27, 2026Common StockSale469US$26.77142,360Indirect
Mar 27, 2026Common StockSale36US$27.37142,360Indirect
Mar 30, 2026Common StockBuy2,992US$25.08145,678Indirect
Mar 30, 2026Common StockBuy4,995US$25.99145,678Indirect
Mar 30, 2026Common StockBuy1,176US$26.70145,678Indirect
Mar 30, 2026Common StockBuy370US$27.68145,678Indirect
Mar 30, 2026Common StockSale518US$25.85145,678Indirect
Mar 30, 2026Common StockSale370US$27.68145,678Indirect

Source

View original at SEC

Related